MEDNAX Reports 2015 Third Quarter Adjusted EPS of $1.10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P on track for muted open as Middle East tensions weigh; AI stocks boost Nasdaq
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
- Piper Sandler Starts SoFi Technologies (SOFI) at Overweight
MEDNAX (MD) Reports In-Line Q3 EPS, Guides Q4 Below Consensus
October 29, 2015 7:43 AM EDTMEDNAX (NYSE: MD) reported Q3 EPS of $1.10, in-line with the analyst estimate of $1.10. Revenue for the quarter came in at $722.3 million versus the consensus estimate of $730.63 million.
MEDNAX sees Q4 2015 EPS of $1.10-$1.14, versus the consensus of $1.16.
For earnings history and earnings-related data on MEDNAX (MD) click here.
... More